This infographic comes from the Health & Science pages of today’s Sydney Morning Herald, which features an interesting feature on pancreatic cancer. Accompanying the story is the infographic below. At first I found it a little confusing as I tried to decode it moving from top to bottom when in fact you need to start […]
MoreJohn Forman is a dedicated if unconventional New Zealand activist, but his cause is one which is putting him at odds with the more vocal and occasionally militant end of the Kiwi activist spectrum – anti-GM campaigners and those who protest against animal testing. Forman, the executive director of the New Zealand Organisation for Rare […]
MoreYesterday was intense. As a judge on the preliminary round of Microsoft’s Imagine Cup, which pits teams of university students against each other in a bid to find the top four most innovative and potentially world-changing projects, it was a blur of powerpoint slides and Dragon’s Den-style questioning as we got through twenty 20-minute pitches […]
MoreIn the world of medical research, Dr Andrew Wakefield is about as controversial a character as you can find. It was Wakefield who was behind claims published in The Lancet in 1998 that pointed towards the measles, mumps and rubella vaccine being linked to autism in children. His paper and subsequent statements to the media […]
MoreWe always do well on these types of lists, the ones that rank countries on how desirable they are to live in. Our pristine surroundings, moderate climate, low rate of crime and corruption, excellent health system, reasonable cost of living and lack of state oppression have helped put us at number 5 on International Living’s […]
MoreThe Sunday Star Times has compiled a table (see below) of university degrees and what graduates from these degrees can expect to earn after a year and three years in the workforce respectively. Not surprisingly, science, health and engineering graduates have much better earning potential than those working in tourism, architecture, agriculture, sports, creative arts and […]
MoreI was only able to briefly duck into the roundtable on genomics that took place in Wellington today, but the fragments of discussion I listened in on were fascinating to say the least. We’ve all heard of 23 and Me, the San Francisco-based company that allows you to set up your own genetic test via […]
MoreThe vast majority of scientists in this country undertake research that is funded by the tax payer and as such, they are often required to prepare reports and give advice to government departments and ministers. The pursuit of evidence-based policy in government is essential and something that should be encouraged. But what happens when the […]
MoreThe long-awaited final report of the 10 year-long, 20 million pound Interphone study into whether mobile phone use can cause brain cancer is set to be published before the end of the year, according to reports from the UK over the weekend. The results are expected to cause some concern for the mobile industry and […]
MoreThe Government has followed up the recommendation of the Chief Science Advisor Professor Sir Peter Gluckman, signaling that it will move to make pseudoephedrine a Class B2 controlled drug, making it prescription-only. UPDATED: While Professor Peter Gluckman recommended option 5 be adopted by the Government calling for a reclassification of pseudoephedribe to Class B2 and […]
More
PETER GRIFFIN 